PFM
DNA icon

Privium Fund Management’s Ginkgo Bioworks DNA Stock Holding History

Privium Fund Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,438
Closed -$236K – 130
2023
Q1 		$236K Hold
4,438
– – 0.08% 71
2022
Q4 		$296K Hold
4,438
– – 0.11% 63
2022
Q3 		$556K Buy
4,438
+2,563
+137% +$305K 0.2% 58
2022
Q2 		$179K Buy
1,875
+1,524
+434% +$186K 0.06% 105
2022
Q1 		$57K Buy
+351
New +$68.3K 0.01% 169

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

Privium Fund Management's DNA Position: Q2 2023 in Review

Privium Fund Management sold out of Ginkgo Bioworks (DNA) in Q2 2023, closing a stake of 4,438 shares — an estimated $236K sold.

Privium Fund Management first reported a position in DNA in Q1 2022 and held it in 5 quarters. The position peaked at $556K in Q3 2022. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.

  • Privium Fund Management reported no remaining Ginkgo Bioworks position as of Q2 2023 after selling out during the quarter.
  • Privium Fund Management sold 4,438 Ginkgo Bioworks shares in Q2 2023, an estimated $236K.
  • Privium Fund Management first reported a position in Ginkgo Bioworks in Q1 2022 and held it in 5 quarters.
  • Privium Fund Management's Ginkgo Bioworks position peaked at $556K in Q3 2022.
  • 315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.

Based on Privium Fund Management's 13F filing for Q2 2023, filed 26 Jul 2023.